drugset / Trial / NCT07257042

Oothpaste Containing 8% Arginine Compared to Colgate Cavity Protection Toothpaste in Reducing Dentinal Hypersensitivity

NCT07257042

Phase 3 Completed 80 enrolled Colgate Palmolive
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to assess clinical efficacy of a toothpaste containing 8% arginine (Colgate-Palmolive Company, New York, NY, USA) to provide dental hypersensitivity relief (tactile and air blast) in comparison to Colgate Cavity Protection Toothpaste (Colgate-Palmolive Company, New York, NY, USA) over an eight-week period.

Timeline

Start
2025-07-14
Primary completion
2025-11-04
Completion
2025-11-04

Drugs

EvaluationDrugModalityDoseRoute
Subject L-arginine Small molecule 8 %